Alternatives to Mavyret If You Can't Fill Your Prescription

Mavyret (glecaprevir/pibrentasvir) is one of the most effective hepatitis C treatments available—but it isn't the only one. If you're struggling to fill your Mavyret prescription due to prior authorization denials, specialty pharmacy limitations, cost issues, or difficulty finding it in stock, you have options. Several other direct-acting antiviral (DAA) regimens are FDA-approved and highly effective for hepatitis C.

Important: Always consult your doctor before switching hepatitis C treatments. The right drug depends on your HCV genotype, cirrhosis status, previous treatment history, kidney function, and other medications you take.

Why Would Someone Need a Mavyret Alternative?

Insurance denied prior authorization for Mavyret

No local pharmacy stocks Mavyret or can fill it quickly enough

Cost is prohibitive even with a savings card

You have a drug interaction that makes Mavyret unsafe (e.g., taking atazanavir or rifampin)

You have moderate or severe liver impairment (Child-Pugh B or C) — Mavyret is contraindicated in these patients

Alternative 1: Epclusa (Sofosbuvir/Velpatasvir)

Epclusa is a pangenotypic once-daily pill—like Mavyret, it works for all HCV genotypes 1 through 6. It's taken for 12 weeks (versus Mavyret's 8 weeks), but it has one major advantage: a generic version is available, making it far more affordable for patients paying out of pocket.

Epclusa is also approved for patients with decompensated cirrhosis (with ribavirin), unlike Mavyret, which is contraindicated in those patients. Cure rates with Epclusa are over 95% across genotypes. Brand Epclusa can cost as little as $5/month with the manufacturer's copay card for commercially insured patients.

Key differences: Epclusa requires 12 weeks of treatment; Mavyret can be done in 8 weeks for most patients. Epclusa interacts with acid-suppressing medications (PPIs, antacids), while Mavyret generally does not.

Alternative 2: Harvoni (Ledipasvir/Sofosbuvir)

Harvoni is approved for HCV genotypes 1, 4, 5, and 6. If you have genotype 1 (the most common in the U.S.), Harvoni is an effective option. Treatment duration is typically 8–12 weeks. Generic ledipasvir/sofosbuvir is available, significantly reducing cost.

Unlike Mavyret, Harvoni can be used in patients with more advanced liver disease. However, it does have interactions with antacids and PPIs (must be taken 4 hours apart or avoided), and it is not recommended for genotypes 2 or 3.

Alternative 3: Zepatier (Elbasvir/Grazoprevir)

Zepatier is approved for HCV genotypes 1 and 4. It's a once-daily pill taken for 12–16 weeks. It's a solid option for patients with these genotypes, particularly those with chronic kidney disease, as it doesn't require dose adjustment for renal impairment.

Zepatier is NOT recommended for genotypes 2, 3, 5, or 6. It also has restrictions in patients with moderate or severe liver impairment. Merck's patient assistance program provides free Zepatier to eligible uninsured patients.

Alternative 4: Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)

Vosevi is a triple-combination DAA approved for all genotypes. It's specifically indicated for patients who have previously been treated with a NS5A inhibitor-containing regimen (such as Harvoni or Epclusa) and didn't achieve a cure—or for certain genotype 3 patients with cirrhosis who are treatment-naive. Treatment is 12 weeks.

Vosevi is not a first-line option for most patients but is valuable in treatment failures where other DAAs haven't worked.

How Do These Alternatives Compare to Mavyret?

All four alternatives above are highly effective, with cure rates above 95%. Here's a quick comparison:

Shortest treatment: Mavyret (8 weeks, most patients)

Generic available: Epclusa (sofosbuvir/velpatasvir) and Harvoni (ledipasvir/sofosbuvir)

OK for decompensated cirrhosis: Epclusa (with ribavirin); Mavyret, Zepatier are contraindicated

Pangenotypic (all genotypes): Mavyret, Epclusa, Vosevi

Approved for acute HCV: Mavyret only (as of June 2025)

How to Find Any HCV Medication in Stock Near You

Whether you're looking for Mavyret or an alternative like Epclusa, medfinder can help. medfinder calls pharmacies near you to check which ones have your medication in stock and can fill your prescription. You can also read our guide on how to find Mavyret in stock near you for more strategies.